Who invested in Cureety

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Healthcare

Funding summaryUpdated 26 Oct 2026

$5.7Mraised across 1 round since 2022, from 1 source

Latest round: Series A, $5.7MJan 2022
Investors: 1

See who backed them

The rounds

Jan 2022
Series A$5.7M
- Bpifrance
Source recorded

Founders and team

From Cureety's own website: 3 founders, 15 on the team.

François-Guirec ChampoiseauCEO / Co-founder

Sebastien MarquePhD, Cstat CEO co-founder

Hugo BreitweillerChief Product Officer / Co-Founder

Philippe CapartVice President of Business Development
Bruno LempernesseCEO
Charles ParnotChief Scientific Officer
Dr. Guillaume BuiretMedical Coordinator, Clinical Research Unit
Dr. Philippe SpiessOncologist, Chief of Clinical Innovation
Florent DarraultChief Marketing Officer
Misha KaurChief Operating Officer
Pascal OgnibeneChief Technical Officer
Dr. Carole HelisseyOncologist, Head of Clinical Research
Guillaume GaudHead of Life Sciences
Dr Philippe SouchoisM.D., Medical Director
Dr. Maya GutierrezChairman of the Scientific Committee
Dr. Noémie StuderPain Medicine Physician, Director of Supportive Care
Nicolas BéginGeneral Manager
Tom SmithExecutive Managing Director

AdvisersDeborah BoyleDr. Hope S. RugoMoffitt Cancer CenterPeter MacCallum Cancer Centre

Everyone who backed them

BpifranceGovernment1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Cureety as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.